Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery
- PMID: 17998460
- DOI: 10.1161/CIRCULATIONAHA.107.698977
Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery
Abstract
Background: Red blood cell transfusion can both benefit and harm. To inform decisions about transfusion, we aimed to quantify associations of transfusion with clinical outcomes and cost in patients having cardiac surgery.
Methods and results: Clinical, hematology, and blood transfusion databases were linked with the UK population register. Additional hematocrit information was obtained from intensive care unit charts. Composite infection (respiratory or wound infection or septicemia) and ischemic outcomes (myocardial infarction, stroke, renal impairment, or failure) were prespecified as coprimary end points. Secondary outcomes were resource use, cost, and survival. Associations were estimated by regression modeling with adjustment for potential confounding. All adult patients having cardiac surgery between April 1, 1996, and December 31, 2003, with key exposure and outcome data were included (98%). Adjusted odds ratios for composite infection (737 of 8516) and ischemic outcomes (832 of 8518) for transfused versus nontransfused patients were 3.38 (95% confidence interval [CI], 2.60 to 4.40) and 3.35 (95% CI, 2.68 to 4.35), respectively. Transfusion was associated with increased relative cost of admission (any transfusion, 1.42 times [95% CI, 1.37 to 1.46], varying from 1.11 for 1 U to 3.35 for >9 U). At any time after their operations, transfused patients were less likely to have been discharged from hospital (hazard ratio [HR], 0.63; 95% CI, 0.60 to 0.67) and were more likely to have died (0 to 30 days: HR, 6.69; 95% CI, 3.66 to 15.1; 31 days to 1 year: HR, 2.59; 95% CI, 1.68 to 4.17; >1 year: HR, 1.32; 95% CI, 1.08 to 1.64).
Conclusions: Red blood cell transfusion in patients having cardiac surgery is strongly associated with both infection and ischemic postoperative morbidity, hospital stay, increased early and late mortality, and hospital costs.
Comment in
-
Blood transfusion in cardiac surgery: a silent epidemic revisited.Circulation. 2007 Nov 27;116(22):2523-4. doi: 10.1161/CIRCULATIONAHA.107.739094. Circulation. 2007. PMID: 18040038 Review. No abstract available.
-
Letter by Augoustides regarding article, "Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery".Circulation. 2008 Jun 24;117(25):e506; author reply e507. doi: 10.1161/CIRCULATIONAHA.107.760843. Circulation. 2008. PMID: 18574052 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous